Currently Viewing:
Currently Reading
A New Target for CAR T Cells Achieves Remission in Resistant Pediatric B-ALL
November 21, 2017 – Surabhi Dangi-Garimella, PhD
Recent Study Shows ADHD to Be an Assortment of Different Disorders
November 21, 2017 – Samatha DiGrande
Eosinophil Count in Sputum, Not Blood, Is Better Predictor of COPD Severity in Smokers
November 21, 2017 – Christina Mattina
Study Compares Methotrexate-Only Versus Combination Therapy in Early RA
November 21, 2017 – Kelly Davio
What We're Reading: Private Care in VA; Arizona Medicaid Expansion; Parkinson's Drug Update
November 21, 2017 – AJMC Staff
JDRF Announces Anthem Policy Change on Medtronic Artificial Pancreas
November 21, 2017 – Mary Caffrey
Survey Identifies Americans' Preferences for Pain Management
November 20, 2017 – Jaime Rosenberg
Determining the Risk of Chemotherapy-Induced Neutropenia to Guide Use of Colony-Stimulating Factors
November 20, 2017 – AJMC Staff
How the Gut Microbiome Is Affecting Immunotherapy Response
November 20, 2017 – Laura Joszt

Former Lead of Aetna's Oncology Program, Dr Michael Kolodziej, Joins Flatiron Health

AJMC Staff
Michael Kolodziej, MD, has joined Flatiron Health as national medical director, Managed Care Strategy.
Michael Kolodziej, MD, has joined Flatiron Health as national medical director, Managed Care Strategy. With his blended experience of a practicing oncologist and a payer, Kolodziej will potentiate the development of alternate payment programs for community oncology clinics.

Flatiron Health, which provides technology platforms to the oncology community, has been a pathbreaker in supporting oncologists as they adapt to new reimbursement models. At Aetna, Kolodziej actively worked with community oncology practices as they developed care delivery and payment programs such as medical homes. He was also involved in establishing a value-based medical home collaboration with the University of Chicago Medicine; the pilot project, which kicked off a year back, enrolled Aetna members who were receiving treatment for breast, lung, and colon cancer at the University.

In the press release, Flatiron Health’s cofounder and chief executive officer, Nat Turner, said of Kolodziej that he “brings a wealth of expertise across providers and commercial payers, and will be critical to Flatiron Health’s strategic growth as we continue to evolve in parallel with today’s changing reimbursement environment. We are thrilled to welcome him to our team and believe his deep knowledge will enable us to further develop our innovative value-based care solution for providers facing a growing number of alternative payment programs.”

According to Kolodziej, “Flatiron Health has the technology and analytics expertise to help payers and providers streamline these complex processes, and I am honored to help guide and grow our program for the benefit of the greater oncology community.”

Copyright AJMC 2006-2017 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome the the new and improved, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up

Sign In

Not a member? Sign up now!